Compugen Integrates Ultima Genomics' Sequencing Tech into Unigen Platform
Compugen has enhanced its AI/ML predictive computational discovery platform, Unigen, by integrating Ultima Genomics' single-cell genomics sequencing technology announced in a press release. This collaboration aims to improve the understanding of tumor biology and immune regulation by combining Compugen's computational tools with Ultima's UG 100 sequencing platform.
The integration has shown high consistency in single-cell expression levels, offering a potential advantage for demarcating transcript termination. This advancement was presented at the Advances in Genome Biology and Technology (AGBT) 2025 General Meeting, highlighting the potential of this technology to uncover new regulatory mechanisms in immuno-oncology.
Compugen plans to leverage Ultima's technology further to develop proprietary single-cell atlases, accelerating the discovery of new immunotherapies. The collaboration underscores the potential of combining large-scale data with AI/ML techniques to transform applications constrained by conventional sequencing technology.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 31 AI Agent Controls Brain Injection in Live Mouse After Claude Opus Refuses Oct 31 Patient Sues Allegheny Health Network and Highmark Over Abridge AI Recordings Oct 31 OpenAI Releases GPT-Rosalind-6 for Approved Biology Researchers Oct 30 Surveys Find Widespread AI Chatbot Use Among Teens and Tweens Oct 30 Widow Sues OpenAI and Luka Over Husband's SuicideLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Illumina Launches BioInsight Platform for Genomic Research
INmune Bio and QCi Apply Quantum Computing to XPro Research
Illumina Adds Three Research Tools to BioInsight Platform
Flagship Pioneering Merges Three Biotech Platforms Into Etcelera
Lunit and Discovery Life Sciences Partner on AI Tissue Analysis
Daily AI Brief: the AI news that matters, in your inbox.